Phase 2 Narcolepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 65 years old
- Your body mass index (a measure of body weight relative to height) is between 17 and 37
- You have been diagnosed with Narcolepsy Type 1, Narcolepsy Type 2, or Idiopathic Hypersomnia (a sleep disorder causing excessive daytime sleepiness) based on recognised medical guidelines
- You are willing and able to stop taking any current medications used to treat your narcolepsy or idiopathic hypersomnia
- You are willing and able to follow all additional requirements set out by the trial
Who may not be able to join:
- You have another medical condition (other than Narcolepsy Type 1, Type 2, or Idiopathic Hypersomnia) that also causes excessive daytime sleepiness
- You have a significant condition affecting the heart, lungs, stomach or digestive system, liver, kidneys, blood, hormones, nerves, or mental health, or you have or have had cancer (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1 617-468-5770
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious TEAEs; Number of Participants With Abnormal Changes From Baseline in Laboratory Tests; Number of Participants With Abnormal Change From Baseline in Vital Signs; Number of Participants With Abnormal Change From Baseline in Electrocardiograms (ECG); Number of Participants With Suicidal Ideation or Suicidal Behavior as Measured Using Columbia-Suicide Severity Rating Scale (C-SSRS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.